Bailin Tu
15Patents
4h-index
42Co-inventors
56Inventor score
Filing activity: Dec 5, 2006 → Apr 17, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8741287B2 | PlGF-1 assay and kits and components thereof | Physics | 14 | Active |
| US8030026B2 | Antibodies to troponin I and methods of use thereof | Chemistry; Metallurgy | 12 | Active |
| US7858752B2 | Recombinant antibodies against hepatitis C virus and methods of obtaining and using same | Chemistry; Metallurgy | 9 | Active |
| US8993248B2 | Truncated human vitamin D binding protein and mutation and fusion thereof and related materials and methods of use | Chemistry; Metallurgy | 6 | Active |
| US7998480B2 | Human BNP immunospecific antibodies | Emerging Cross-Sectional Technologies | 3 | Active |
| US8846036B2 | Antibodies that bind to mammalian NGAL and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US8394606B2 | Neutrophil gelatinase-associated lipocalin (NGAL) protein isoforms enriched from urine and recombinant chinese hamster ovary (CHO) cells and related compositions, antibodies, and methods of enrichment, analysis and use | Physics | 2 | Active |
| USRE45763E1 | Antibodies to troponin I and methods of use thereof | General | 1 | Active |
| US8734793B2 | Recombinant antibodies against hepatitis C virus and methods of obtaining and using same | Chemistry; Metallurgy | 1 | Active |
| US10215754B2 | Anti-T. cruzi antibodies and methods of use | Emerging Cross-Sectional Technologies | 0 | Active |
| US9073984B2 | Anti-T. cruzi antibodies and methods of use | Emerging Cross-Sectional Technologies | 0 | Active |
| US9482667B2 | Anti-T. cruzi antibodies and methods of use | Emerging Cross-Sectional Technologies | 0 | Active |
| US11421023B2 | Anti-GP73 monoclonal antibodies and methods of obtaining the same | Physics | 0 | Active |
| US9469686B2 | Anti-GP73 monoclonal antibodies and methods of obtaining the same | Physics | 0 | Active |
| US10308709B2 | Anti-GP73 monoclonal antibodies and methods of obtaining the same | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.